Related Experiment Video
Updated: Mar 14, 2026

06:13
Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
Published on: January 16, 2026
77
Armadillo Repeat-Containing Protein 8 (ARMC8) Silencing Inhibits Proliferation and Invasion in Osteosarcoma Cells
1Department of Orthopedics, Huaihe Hospital of Henan University, Kaifeng, Henan Province, P.R. China.
Oncology Research
|October 8, 2016
Summary
Armadillo repeat-containing protein 8 (ARMC8) is overexpressed in osteosarcoma. Silencing ARMC8 inhibits osteosarcoma cell proliferation, migration, and invasion, suggesting ARMC8 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Armadillo repeat-containing protein 8 (ARMC8) is implicated in cell regulation and tumorigenesis.
- The specific role and expression of ARMC8 in osteosarcoma remain largely uncharacterized.
Purpose of the Study:
- To investigate the expression patterns of ARMC8 in osteosarcoma.
- To elucidate the functional role of ARMC8 in osteosarcoma progression.
- To explore the underlying molecular mechanisms of ARMC8 action in osteosarcoma.
Main Methods:
- ARMC8 expression analysis in osteosarcoma cell lines.
- In vitro and in vivo functional assays following ARMC8 knockdown.
- Assessment of epithelial-mesenchymal transition (EMT) markers and signaling pathways (β-catenin, c-Myc, cyclin D1).
Main Results:
- ARMC8 was found to be significantly overexpressed in osteosarcoma cell lines.
- ARMC8 knockdown suppressed osteosarcoma cell proliferation, migration, and invasion in vitro.
- ARMC8 silencing inhibited xenograft tumor growth in vivo and suppressed EMT.
- Knockdown of ARMC8 reduced the expression of β-catenin, c-Myc, and cyclin D1.
Conclusions:
- ARMC8 plays a crucial role in promoting osteosarcoma cell proliferation and invasion.
- ARMC8 silencing demonstrates therapeutic potential by inhibiting osteosarcoma progression.
- ARMC8 represents a promising novel therapeutic target for human osteosarcoma treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
Experimental RNAi
8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K

